Procter & Gamble confirms Pepper as chairman, creates COO post for Jager, reorganizes internationally.
Executive Summary
P&G CREATES NEW TOP-LEVEL POST FOR JAGER, EXPANDS INTERNATIONAL operations with the creation of four geographic divisions to replace the previous two entities, the company announced March 14. The restructuring marks the end of the Artzt era; Procter & Gamble is confirming former President John Pepper, 56, as the replacement for 64-year-old Edwin Artzt as chairman and CEO. Concurrently, the company has created the post of chief operating officer for Durk Jager, formerly exec VP, who will also hold the title of president. The changes go into effect July 1.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth